1. Volume 122, Issue 1, Pages 20-25 (January 2002)
Budesonide in collagenous colitis: A double-blind placebo-controlled trial with histologic follow-up 
Filip Baert, Alain Schmit, Geert D'Haens, Franceska Dedeurwaerdere, Edouard Louis, Marc Cabooter, Martine De Vos, Fernand Fontaine, Serge Naegels, Piet Schurmans, Hedwig Stals, Karel Geboes, Paul Rutgeerts 
Gastroenterology 
Volume 122, Issue 1, Pages (January 2002)
DOI: /gast
Copyright © 2002 American Gastroenterological Association Terms and Conditions

2. Fig. 1
(A) Evolution of the disease activity score during screening and 8-week blinded therapy for budesonide. (B) Evolution of the disease activity score during screening and 8-week blinded therapy for placebo.
Gastroenterology  , 20-25DOI: ( /gast )
Copyright © 2002 American Gastroenterological Association Terms and Conditions

3. Fig. 2
(A) Photomicrograph of CC before treatment showing a thickened subepithelial collagen band, mild, and focal epithelial damage and increased cellularity. (B) CC after treatment. The subepithelial collagen band is mildly thickened and the lamina propria cellularity greatly reduced.
Gastroenterology  , 20-25DOI: ( /gast )
Copyright © 2002 American Gastroenterological Association Terms and Conditions

4. Fig. 3
Evolution of the mean thickness of the collagen band before and after 8 weeks of therapy.
Gastroenterology  , 20-25DOI: ( /gast )
Copyright © 2002 American Gastroenterological Association Terms and Conditions

5. Fig. 4
Evolution of the stool consistency score. *The stool consistency score is a summation of scores 7 days before the visit on a 3-point scale. 0, formed; 1, semiliquid; 2 liquid (P < 0.05).
Gastroenterology  , 20-25DOI: ( /gast )
Copyright © 2002 American Gastroenterological Association Terms and Conditions